Shanghai HeartCare Medical Technology Corporation approved at its AGM held on June 10, 2022 the proposal for the appointment of Mr. Wei Jiawei as an executive Director with effect from June 10, 2022. He will hold office until the end of the current session of the Board.
Shanghai HeartCare Medical Technology Corporation Limited
Equities
6609
CNE100004MN5
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.56 HKD | 0.00% | -4.13% | -37.61% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.61% | 90.74M | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- 6609 Stock
- News Shanghai HeartCare Medical Technology Corporation Limited
- Shanghai Heartcare Medical Technology Corporation Limited Appoints Wei Jiawei as an Executive Director